Future Developments in Radiation Therapy for Endometrial Carcinoma

[1]  P. Koper,et al.  Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[3]  J. Thigpen,et al.  Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group , 2003 .

[4]  S. Kalnicki,et al.  Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. , 2003, Gynecologic oncology.

[5]  John C Roeske,et al.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[6]  Keith D. Jones,et al.  High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. , 2003, Gynecologic oncology.

[7]  P. Roland,et al.  Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. , 2003, Gynecologic oncology.

[8]  P. Koper,et al.  Survival after relapse in patients with endometrial cancer: results from a randomized trial. , 2003, Gynecologic oncology.

[9]  M. Piccart,et al.  Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  John C Roeske,et al.  Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[11]  John C Roeske,et al.  Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[12]  Brady J. McKee,et al.  Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. , 2002, International journal of radiation oncology, biology, physics.

[13]  John C Roeske,et al.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[14]  P. Koper,et al.  The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. , 2001, International journal of radiation oncology, biology, physics.

[15]  A. Mundt,et al.  Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[16]  K. Stelzer,et al.  Radiation therapy in endometrial cancer. , 2001, Best practice & research. Clinical obstetrics & gynaecology.

[17]  B. Jereczek-Fossa Postoperative irradiation in endometrial cancer: still a matter of controversy. , 2001, Cancer treatment reviews.

[18]  D. Petereit,et al.  Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  M. J. Webb,et al.  Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.

[20]  A. Fyles,et al.  Results of radical radiotherapy for recurrent endometrial cancer. , 2000, Gynecologic oncology.

[21]  J. Anderson,et al.  High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. , 2000, International journal of radiation oncology, biology, physics.

[22]  J. Sarkaria,et al.  High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. , 1999, International journal of radiation oncology, biology, physics.

[23]  D. Petereit,et al.  Outpatient vaginal cuff brachytherapy for endometrial cancer. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[24]  J. Hall,et al.  The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists. , 1999, Gynecologic oncology.

[25]  C. Hess,et al.  Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  M. Chadha,et al.  Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. , 1999, Gynecologic oncology.

[27]  T. Fitzgerald,et al.  Brachytherapy for early endometrial carcinoma: a comparative study with long-term follow-up. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[28]  D. Petereit,et al.  Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? , 1999, International journal of radiation oncology, biology, physics.

[29]  C. Hess,et al.  Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. , 1998, Gynecologic oncology.

[30]  H. Yun,et al.  Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. , 1998, Gynecologic oncology.

[31]  J. Jassem,et al.  Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model. , 1998, International journal of radiation oncology, biology, physics.

[32]  B. Clark,et al.  Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy. , 1997, Gynecologic oncology.

[33]  K. Shin,et al.  Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. , 1997, International journal of radiation oncology, biology, physics.

[34]  J. Fanning,et al.  Surgical Staging and High Dose Rate Brachytherapy for Endometrial Cancer: Limiting External Radiotherapy to Node‐Positive Tumors , 1996, Obstetrics and gynecology.

[35]  I. Strøyer,et al.  Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low‐risk cases , 1996 .

[36]  M. Carey,et al.  Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. , 1995, Gynecologic oncology.

[37]  D. Schultz,et al.  Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. Piver,et al.  Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus. , 1993, International journal of radiation oncology, biology, physics.

[39]  M. Tattersall,et al.  The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer , 1993, International Journal of Gynecologic Cancer.

[40]  D. Schultz,et al.  Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. , 1992, International journal of radiation oncology, biology, physics.

[41]  T. Fitzgerald,et al.  Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. , 1992, International journal of radiation oncology, biology, physics.

[42]  K. Greven,et al.  Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation. , 1991, International journal of radiation oncology, biology, physics.

[43]  W. Curran,et al.  Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium. , 1990, International journal of radiation oncology, biology, physics.

[44]  K. Dusenbery,et al.  Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer. , 1990, International journal of radiation oncology, biology, physics.

[45]  R. Holloway,et al.  Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates. , 1990, Gynecologic oncology.

[46]  P. Koper,et al.  Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. , 1990, International journal of radiation oncology, biology, physics.

[47]  R. Kurman,et al.  Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. , 1990, Gynecologic oncology.

[48]  W. Curran,et al.  Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system. , 1988, International journal of radiation oncology, biology, physics.

[49]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[50]  W. H. Bond Early uterine body carcinoma: has post-operative vaginal irradiation any value? , 1985, Clinical radiology.

[51]  V. Abeler,et al.  Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.